Company intelligence / Profile preview

Jiecheng Med-Tech Development

Suzhou, China

Ownership: Private
Development stage: Other

Overview

Suzhou Jiecheng Medical Technology is a medical device company specializing in artificial heart valves and implants. It developed the J-Valve TA (transapical TAVR), which received NMPA approval in 2017 and was the first approved transapical TAVR in China.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Jiecheng Med-Tech Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiecheng Med-Tech Development.

Explore the full profile